Science describes PRIMA as an "investigational" retinal implant designed to combat vision loss caused by GA and AMD. For the time being, the device is commercially available...

Science Corporation announced the European launch of its retinal implant for patients with age-related macular degeneration.

Science Corp. Announces European Commercial Launch of PRIMA, the Only Treatment to Restore Functional Central Vision to Patients with Geographic Atrophy Caused by Age-Related…